2021 annual financial data
Bolt Biotherapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was -4,529.05%.
Operating income was -92,788,000 USD and net income was -98,591,000 USD.
Operating cash flow was -57,066,000 USD.
Get free Bolt Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,260,000 USD
- Operating income
- -92,788,000 USD
- Net income
- -98,591,000 USD
- Operating cash flow
- -57,066,000 USD